Bruker (BRKR) Scheduled to Post Earnings on Wednesday

Bruker (NASDAQ:BRKRGet Free Report) will post its quarterly earnings results on Wednesday, February 7th.

Bruker Trading Down 0.5 %

Shares of BRKR stock opened at $71.81 on Tuesday. Bruker has a fifty-two week low of $53.79 and a fifty-two week high of $84.84. The stock has a market cap of $9.94 billion, a P/E ratio of 33.09, a P/E/G ratio of 2.35 and a beta of 1.14. The business has a fifty day simple moving average of $71.10 and a 200-day simple moving average of $66.05. The company has a quick ratio of 1.04, a current ratio of 1.89 and a debt-to-equity ratio of 0.90.

Bruker Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, December 15th. Investors of record on Friday, December 1st were given a dividend of $0.05 per share. This represents a $0.20 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date was Thursday, November 30th. Bruker’s dividend payout ratio is presently 9.22%.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. ExodusPoint Capital Management LP bought a new position in Bruker during the 4th quarter worth $213,000. Sherbrooke Park Advisers LLC acquired a new position in Bruker during the 2nd quarter worth $207,000. PNC Financial Services Group Inc. boosted its position in Bruker by 8.1% during the 1st quarter. PNC Financial Services Group Inc. now owns 2,904 shares of the medical research company’s stock worth $187,000 after acquiring an additional 217 shares during the period. Canada Pension Plan Investment Board acquired a new position in Bruker during the 1st quarter worth $122,000. Finally, Point72 Hong Kong Ltd acquired a new position in Bruker during the 1st quarter worth $107,000. 79.78% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms recently commented on BRKR. Wells Fargo & Company began coverage on Bruker in a research report on Tuesday, December 19th. They set an “equal weight” rating and a $72.00 price target on the stock. Wolfe Research began coverage on Bruker in a research report on Wednesday, December 13th. They set an “outperform” rating and a $80.00 price target on the stock. Finally, JPMorgan Chase & Co. reduced their price target on Bruker from $70.00 to $65.00 and set a “neutral” rating on the stock in a research report on Tuesday, October 17th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat.com, Bruker currently has an average rating of “Hold” and a consensus target price of $80.00.

Get Our Latest Stock Report on Bruker

About Bruker

(Get Free Report)

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies.

Read More

Earnings History for Bruker (NASDAQ:BRKR)

Receive News & Ratings for Bruker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bruker and related companies with MarketBeat.com's FREE daily email newsletter.